Difference between revisions of "Team:ETH Zurich"

Line 150: Line 150:
  
  
−
<!--Footer is currently fucked up on landing page for some reason
+
 
−
{{ETH_Zurich/footer2}}-->
+
 
−
<!--{{Team:ETH_Zurich/ETHZ_footer}}-->
+
 
−
<!--Link: https://2017.igem.org/wiki/index.php?title=Template:Team:ETH_Zurich/ETHZ_footer-->
+
{{ETH_Zurich/footer2}}
  
  

Revision as of 14:38, 7 October 2017



Cancer kills over 8 million people every year. That's the entire population of Switzerland!

We need more specific therapies because current approaches result in many side-effects.
That's why we created CATE: Cancer-Targeting E. coli.

Learn more
CATE consists of the non-pathogenic bacterium E. coli Nissle that has the intrinsic ability to home specifically in tumors.

We are engineering E. coli Nissle to carry a MRI contrast and a cytotoxic agent so it can deliver both components to tumor sites.

Project description